TY - CHAP M1 - Book, Section TI - Esophageal Cancer A1 - Ursem, Carling A1 - McQuaid, Kenneth R. A2 - Papadakis, Maxine A. A2 - McPhee, Stephen J. A2 - Rabow, Michael W. A2 - McQuaid, Kenneth R. Y1 - 2023 N1 - T2 - Current Medical Diagnosis & Treatment 2023 AB - Key Clinical Updates in Esophageal CancerFor patients who complete neoadjuvant chemoradiation and undergo a complete resection but are found to have residual cancer in the resection specimen, a year of adjuvant immunotherapy with nivolumab is recommended.Ahmed O et al. Clin Gastroenterol Hepatol. [PMID: 33813072] SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/10/04 UR - accessmedicine.mhmedical.com/content.aspx?aid=1193162277 ER -